Cooper, Christopher

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cooper, Christopher's trades of Navco Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-23 2025-01-22
S Sale
46,021 -4.0%
436.14
CA$3,889,358 		46,021 -4.0% 436.14 CA$3,889,358
2023-11-01 2023-10-31
S Sale
59,727
58.63
CA$1,722,430 		59,727 58.63 CA$1,722,430
2023-11-01 2023-10-25
S Sale
33,357 +9.4%
63.52
CA$414,919 		33,357 +9.4% 63.52 CA$414,919
2023-11-01 2023-10-25
B Purchase
200,000 +58.0%
1.15
CA$230,000 		200,000 +58.0% 1.15 CA$230,000
2023-11-01 2023-10-25
B Purchase
250,000 +263.6%
0.55
CA$137,000 		250,000 +263.6% 0.55 CA$137,000
2023-08-23 2023-08-23
S Sale
106,000 -42.4%
1.00
CA$106,000 		106,000 -42.4% 1.00 CA$106,000
2023-07-27 2023-07-26
B Purchase
94,826
0.73
CA$69,602 		94,826 0.73 CA$69,602
2023-02-01 2023-02-01
S Sale
95,500 -38.1%
0.37
CA$35,335 		95,500 -38.1% 0.37 CA$35,335
2023-02-01 2023-01-31
S Sale
31,500 -11.2%
0.40
CA$12,600 		31,500 -11.2% 0.40 CA$12,600
2023-02-01 2023-01-31
S Sale
18,000 -6.0%
0.41
CA$7,380 		18,000 -6.0% 0.41 CA$7,380
2023-02-01 2023-01-31
B Purchase
300,000
0.15
CA$45,000 		300,000 0.15 CA$45,000